207 related articles for article (PubMed ID: 15827867)
21. External ophthalmoplegia with severe progressive multiorgan involvement associated with the mtDNA A3243G mutation.
Hansrote S; Croul S; Selak M; Kalman B; Schwartzman RJ
J Neurol Sci; 2002 May; 197(1-2):63-7. PubMed ID: 11997068
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial DNA defects in Brazilian patients with chronic progressive external ophthalmoplegia.
Kiyomoto BH; Tengan CH; Moraes CT; Oliveira AS; Gabbai AA
J Neurol Sci; 1997 Nov; 152(2):160-5. PubMed ID: 9415537
[TBL] [Abstract][Full Text] [Related]
23. Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: can we predict progression?
Auré K; Ogier de Baulny H; Laforêt P; Jardel C; Eymard B; Lombès A
Brain; 2007 Jun; 130(Pt 6):1516-24. PubMed ID: 17439982
[TBL] [Abstract][Full Text] [Related]
24. [A case of mitochondrial encephalomyopathy showing ophthalmoplegia, diabetes mellitus and hearing loss associated with the A3243G mutation of mitochondrial DNA].
Hoshino S; Tamaoka A; Ohkoshi N; Shoji S; Goto Y
Rinsho Shinkeigaku; 1997 Apr; 37(4):326-30. PubMed ID: 9248343
[TBL] [Abstract][Full Text] [Related]
25. Isolated hearing loss associated with T7511C mutation in mitochondrial DNA.
Yamasoba T; Tsukuda K; Suzuki M
Acta Otolaryngol Suppl; 2007 Dec; (559):13-8. PubMed ID: 18340555
[TBL] [Abstract][Full Text] [Related]
26. [Parathyroid dysfunction and mitochondrial diseases].
Ohno Y; Aoki N
Nihon Rinsho; 2002 Apr; 60 Suppl 4():647-51. PubMed ID: 12013964
[No Abstract] [Full Text] [Related]
27. CPEO and KSS differ in the percentage and location of the mtDNA deletion.
López-Gallardo E; López-Pérez MJ; Montoya J; Ruiz-Pesini E
Mitochondrion; 2009 Sep; 9(5):314-7. PubMed ID: 19410662
[TBL] [Abstract][Full Text] [Related]
28. [Chronic progressive external ophthalmoplegia (CPEO); mitochondrial DNA deletion, brain MRI and electrophysiological studies].
Nakagawa M; Tokimura M; Kuriyama M; Higuchi I; Osame M
Rinsho Shinkeigaku; 1991 Sep; 31(9):981-6. PubMed ID: 1769162
[TBL] [Abstract][Full Text] [Related]
29. A case of Kearns-Sayre syndrome with autoimmune thyroiditis and possible Hashimoto encephalopathy.
Berio A; Piazzi A
Panminerva Med; 2002 Sep; 44(3):265-9. PubMed ID: 12094144
[TBL] [Abstract][Full Text] [Related]
30. Retinal manifestations in mitochondrial diseases associated with mitochondrial DNA mutation.
Isashiki Y; Nakagawa M; Ohba N; Kamimura K; Sakoda Y; Higuchi I; Izumo S; Osame M
Acta Ophthalmol Scand; 1998 Feb; 76(1):6-13. PubMed ID: 9541428
[TBL] [Abstract][Full Text] [Related]
31. Hearing loss in patients with Behçet's disease: an audiological and transient evoked otoacoustic emission study.
Aslan S; Serarslan G; Savas N; Teksoz E; Dagli S
J Laryngol Otol; 2010 Jan; 124(1):10-5. PubMed ID: 19785925
[TBL] [Abstract][Full Text] [Related]
32. Exophthalmos in Kearns-Sayre syndrome.
Tauber J; Polla DJ; Park S
J AAPOS; 2019 Oct; 23(5):295-297. PubMed ID: 31158487
[TBL] [Abstract][Full Text] [Related]
33. Quantitative analysis of mitochondrial DNA deletion in paraffin embedded muscle tissues from patients with KSS and CPEO.
Kim SH; Chi JG; Reith A; Kadenbach B
Biochim Biophys Acta; 1997 May; 1360(3):193-5. PubMed ID: 9197460
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial cytochrome b gene deletion in Kearns-Sayre syndrome associated with a subclinical type of peripheral neuropathy.
Zanssen S; Molnar M; Buse G; Schröder JM
Clin Neuropathol; 1998; 17(6):291-6. PubMed ID: 9832255
[TBL] [Abstract][Full Text] [Related]
35. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
Hoth S
Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
[TBL] [Abstract][Full Text] [Related]
36. Sequence homology at the breakpoint and clinical phenotype of mitochondrial DNA deletion syndromes.
Sadikovic B; Wang J; El-Hattab AW; Landsverk M; Douglas G; Brundage EK; Craigen WJ; Schmitt ES; Wong LJ
PLoS One; 2010 Dec; 5(12):e15687. PubMed ID: 21187929
[TBL] [Abstract][Full Text] [Related]
37. Tone-burst and click-evoked otoacoustic emissions in subjects with hearing loss above 0.25, 0.5, and 1 kHz.
Jedrzejczak WW; Kochanek K; Trzaskowski B; Pilka E; Skarzynski PH; Skarzynski H
Ear Hear; 2012; 33(6):757-67. PubMed ID: 22710662
[TBL] [Abstract][Full Text] [Related]
38. [Mitochondrial DNA deletions in Kearns-Sayre syndrome].
Carod-Artal FJ; Lopez Gallardo E; Solano A; Dahmani Y; Herrero MD; Montoya J
Neurologia; 2006 Sep; 21(7):357-64. PubMed ID: 16977556
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of large-scale mitochondrial DNA deletions in an adult Finnish population.
Remes AM; Majamaa-Voltti K; Kärppä M; Moilanen JS; Uimonen S; Helander H; Rusanen H; Salmela PI; Sorri M; Hassinen IE; Majamaa K
Neurology; 2005 Mar; 64(6):976-81. PubMed ID: 15781811
[TBL] [Abstract][Full Text] [Related]
40. [Chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome : interdisciplinary diagnosis and therapy].
Wabbels B; Ali N; Kunz WS; Roggenkämper P; Kornblum C
Ophthalmologe; 2008 Jun; 105(6):550-6. PubMed ID: 18373100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
